카이
카이바이오텍 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 새한산업, was filed 20 Sept 2024.
카이바이오텍: what insiders have been doing
Every trade that managers of 카이바이오텍 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. 카이바이오텍 has had no insider filing for more than a year; the last one goes back to 20 September 2024.
For comparison within the same sector, see the insider buying recorded at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Insider Decl.
13
Thresholds
n/a
Buy Volume
n/a
7 ops. · all time
Sell Volume
n/a
6 ops. · all time
Financial data
· cache
Last declaration on 20 September 2024
Declarations13 total
- 136,363 sharesKRXDART:20240920000369Canonical exit: 11 Dec 2024 (T+90)
- ShareKRXDART:20240920000341Canonical exit: 11 Dec 2024 (T+90)
- 136,363 sharesKRXDART:20240919000294Canonical exit: 1 Aug 2024 (T+90)
- ShareKRXDART:20240919000216Canonical exit: 1 Aug 2024 (T+90)
- 136,363 sharesKRXDART:20240913000106
- 136,363 sharesKRXDART:20240508000405
- ShareKRXDART:20221230000223Canonical exit: 30 Mar 2023 (T+90)
- 136,363 sharesKRXDART:20221230000367
- 136,363 sharesKRXDART:20221229000723
- 136,363 sharesKRXDART:20221229000686
- ShareKRXDART:20221229000411Canonical exit: 29 Mar 2023 (T+90)
- ShareKRXDART:20221229000431Canonical exit: 29 Mar 2023 (T+90)
- 136,363 sharesKRXDART:20221229000387
13 of 13 declarations
About 카이바이오텍
Kai Biotech is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for healthcare.
